13089-48-0

Basic information

• Product Name: N-Benzoylcytidine
• Synonyms: N(sup 4)benzoylcytidine;N4-Bz-rC;Bz-rC;NSC 242979;N-(1-(3,4-Dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyriMidin-4-yl)benzaMide;4N-Benzoyl Cytidine;N4-Benzoylcytidine;N-(1-(3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzam
• CAS NO: 13089-48-0
• Molecular Formula: C₁₆H₁₇N₃O₆
• Molecular Weight: 347.32
• EINECS: 2017-001-1
• Product Categories: Nucleosides, Nucleotides & Related Reagents;Bases & Related Reagents;Nucleotides;Nucleosides;Oligonucleotide Synthesis;Specialty Synthesis;Nucleotides and Nucleosides;Biochemistry;Nucleosides and their analogs
• Mol File: 13089-48-0.mol
• Article Data: 31

Chemical Properties

• Melting Point: 230-234 °C (dec.)(lit.)
• Appearance: White to Off-white/Crystalline Powder
• Density: 1.59 g/cm³
• Refractive Index: 46 ° (C=1, DMSO)
• Storage Temp.: Store at 0°C
• Solubility: Soluble in 1N NaOH at 10mg/ml. Also soluble in methanol or DMSO
• PKA: 8.61±0.20(Predicted)
• CAS DataBase Reference: N-Benzoylcytidine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Benzoylcytidine(13089-48-0)
• EPA Substance Registry System: N-Benzoylcytidine(13089-48-0)

Safety Data

• Safety Statements: 24/25
• WGK Germany: 3
• Hazardous Substances Data: 13089-48-0(Hazardous Substances Data)

Usage

Chemical Properties

Slightly Pink Solid

Uses

Different sources of media describe the Uses of 13089-48-0 differently. You can refer to the following data:
1. N4-Benzoylcytidine is a useful building block for oligoribonucleotide synthesis
2. N-Benzoylcytidine is a useful building block for oligoribonucleotide synthesis.

InChI:InChI=1/C16H17N3O6/c20-8-10-12(21)13(22)15(25-10)19-7-6-11(18-16(19)24)17-14(23)9-4-2-1-3-5-9/h1-7,10,12-13,15,20-22H,8H2,(H,17,18,23,24)/t10-,12-,13-,15-/m1/s1

Upstream product

• 39946-94-6 4-N-benzoyl-2',3'-O-isopropylidenecytidine 
• 69304-43-4 1-[3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-ribofuranosyl]-N⁴-benzoylcytosine 
• 1314034-30-4 N₄-benzoyl-3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-2'-O-(methoxymethyl)cytidine 
• 65-85-0 benzoic acid 
• 65-46-3 CYTIDINE 
• 97626-95-4 N⁴-benzoyl-1-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-cytosine 
• 80015-55-0 2'-O-(4-methoxybenzyl)cytidine 
• 98-88-4 benzoyl chloride 
• 118684-37-0 O^2',O^3',O^5'-tris-trimethylsilyl-N⁴-benzoylcytidine 
• 263009-01-4 4-N-Benzoyl-2'-O-[1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl]cytidine 
• 147490-72-0 4-N-benzoyl-2'-O-<1-(2-fluorophenyl)-4-methoxypiperidin-4-yl>cytidine 
• 93-97-0 benzoic acid anhydride 
• 80015-59-4 2'-O-(4-methoxybenzyl)-N⁴-benzoylcytidine 

Downstream Products

• 97626-95-4 N⁴-benzoyl-1-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-cytosine 
• 39946-95-7 N₄-benzoyl-2',3'-O-isopropylidene-5'-O-toluenesulfonylcytidine 
• 163889-46-1 N-{1-[(2R,3R,4R,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-trimethylsilanyl-ethoxymethoxy)-tetrahydro-furan-2-yl]-2-oxo-1,2-dihydro-pyrimidin-4-yl}-benzamide 
• 163889-38-1 N-{1-[(4aR,6R,7R,7aR)-2,2-Di-tert-butyl-7-(2-trimethylsilanyl-ethoxymethoxy)-tetrahydro-furo[3,2-d][1,3,2]dioxasilin-6-yl]-2-oxo-1,2-dihydro-pyrimidin-4-yl}-benzamide 
• 163889-42-7 N-{1-[(2R,3R,4R,5R)-4-Hydroxy-5-hydroxymethyl-3-(2-trimethylsilanyl-ethoxymethoxy)-tetrahydro-furan-2-yl]-2-oxo-1,2-dihydro-pyrimidin-4-yl}-benzamide 
• 310434-48-1 4-N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-{[6-(trifluoroacetamido)hexyl]carbamoyl}cytidine 
• 310434-46-9 4-N-Benzoyl-3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-2'-O-{[6-(trifluoroacetamido)hexyl]carbamoyl}cytidine 
• 310434-47-0 4-N-Benzoyl-2'-O-{[6-(trifluoroacetamido)hexyl]carbamoyl}cytidine 
• 310434-45-8 4-N-Benzoyl-2'-O-(imidazol-1-ylcarbonyl)-3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)cytidine 
• 309967-60-0 2'-O-[bis(2-cyano-1,1-dimethylethoxy)thiophosphoryl]-5'-O-(4,4'-dimethoxytrityl)-4-N-benzoylcytidine 
• 309967-56-4 2'-O-[bis(2-cyano-1,1-dimethylethoxy)thiophosphoryl]-4-N-benzoylcytidine 
• 72409-30-4 N⁴-benzoyl-2'-O-(tert-butyldimethylsilyl)-5'-O-(4-monomethoxytrityl)cytidine 
• 501014-32-0 N⁴-benzoyl-2'-O-(tert-butyldimethylsilyl)-3'-keto-5'-O-(4-monomethoxytrityl)cytidine 
• 501014-34-2 N⁴-benzoyl-2'-O-(tert-butyldimethylsilyl)-3'-C-(trimethylsilylethynyl)cytidine 

Relevant articles and documents

Microwaves - A powerful tool for the base protection of cytidine

Use of microwaves for the base protection of cytidine is described. The procedure gives N-acylcytidine in nearly quantitative yield in 40-60 seconds.

Synthesis method for azvudine

The invention discloses a synthesis method for azvudine. The method comprises the following steps of carrying out a hydroxyl substitution reaction on a compound 4 and an iodine elementary substance toobtain a compound 5, carrying out an elimination reaction on an iodo group in the compound 5 to obtain a compound 6, reacting the compound 6 with azide under the catalysis of ICl to obtain a compound7, carrying out an iodine substitution reaction on the compound 7 and carboxylic acid to obtain a compound 8, and carrying out an amino and hydroxyl deprotection reaction on the compound 8 to obtaina compound 9, namely the alzvudine. Compared with an existing synthesis method, the synthesis method has the advantages of short synthesis route, shortened reaction time, mild reaction conditions andeasily controlled reaction process, can be used for preparing the alzvudine with the lower cost, and has a very good application prospect.

New tools in nucleoside toolbox of tick-borne encephalitis virus reproduction inhibitors

Design and development of nucleoside analogs is an established strategy in the antiviral drug discovery field. Nevertheless, for many viruses the coverage of structure-activity relationships (SAR) in the nucleoside chemical space is not sufficient. Here we present the nucleoside SAR exploration for tick-borne encephalitis virus (TBEV), a member of Flavivirus genus. Promising antiviral activity may be achieved by introduction of large hydrophobic substituents in the position 6 of adenosine or bulky silyl groups to the position 5′. Introduction of methyls to the ribose moiety does not lead to inhibition of TBEV reproduction. Possible mechanisms of action of these nucleosides include the inhibition of viral entry or interaction with TBEV non-structural protein 5 methyltransferase or RNA-dependent RNA polymerase domains.